|
Status |
Public on Jan 17, 2024 |
Title |
JC21_G007LK |
Sample type |
RNA |
|
|
Source name |
Human Colorectal Cancer
|
Organism |
Homo sapiens |
Characteristics |
cell line: JC21 treatment: 0.3 uM G007LK for 24 h
|
Treatment protocol |
The patient-derived CRC cells, JC21 and JC475, were left untreated (DMSO) or treated with 0.3 µM G007LK or RK582 for 24 h.
|
Growth protocol |
JC21 and JC475 cells were maintained in in the StemPro ESC medium (Life technologies) supplemented with 10 μM Y-27632 in a humidified atmosphere of 5% CO2 and 95% air at 37 °C.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNAs were extracted using Fast Gene RNA Basic kit (Nippon Genetics) according to the manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNAs were prepared according to the standard Affymetrix protocol from 100ng total RNA.
|
|
|
Hybridization protocol |
Standard Affymetrix protocol.
|
Scan protocol |
Standard Affymetrix protocol.
|
Data processing |
Gene-level expression signals were obtained by processing of raw data with the MAS5 procedure using GeneSpring GX (Agilent Technologies).
|
|
|
Submission date |
May 10, 2023 |
Last update date |
Jan 17, 2024 |
Contact name |
Tetsuo Mashima |
E-mail(s) |
ttmjmj@gmail.com
|
Phone |
81-3-3520-0111
|
Organization name |
Japanese Foundation for Cancer Research
|
Department |
Cancer Chemotherapy Center
|
Lab |
Division of Molecular Biotherapy
|
Street address |
Koto-ku, Ariake 3-8-31
|
City |
Tokyo |
ZIP/Postal code |
135-8550 |
Country |
Japan |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE232209 |
Gene expression data of APC-mutated colorectal cancer patient-derived cells treated with tankyrase inhibitors |
|